4.1 Article

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naive HIV-infected patients

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

Pros and cons of therapeutic drug monitoring of antiretroviral agents

DM Burger et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2002)